AXIM Biotechnologies Inc. (OTCMKTS:AXIM) Develops Portfolio of 4 Quantitative Rapid Diagnostic Tests to Target Dry Eye Disease

AXIM Biotechnologies Inc. (OTCMKTS:AXIM), a healthcare solutions company focusing on Dry Eye Disease (DED), announced on April 27, 2022, about successfully developing a rapid quantitative tear test for Lacritin, a tear protein that autonomously promotes tearing and is deficient in… Continue Reading